|
New Biotech Drug and Vaccine Approvals/New Indication Approvals by Year
|  Printer Friendly |
Despite volatility, IPO and investment trends are positive because the fundamentals of the industry are strong. The number of approved biotechnology medicines and vaccines has risen steadily over the last two decades, with the total number of biotech products on the market leaping seven-fold in the last 10 years.
Source: BIO
| Underlying Data |
| Year | Approvals |
| 1982 | 2 |
| 1983 | 0 |
| 1984 | 0 |
| 1985 | 2 |
| 1986 | 5 |
| 1987 | 2 |
| 1988 | 3 |
| 1989 | 5 |
| 1990 | 5 |
| 1991 | 5 |
| 1992 | 3 |
| 1993 | 7 |
| 1994 | 7 |
| 1995 | 16 |
| 1996 | 20 |
| 1997 | 19 |
| 1998 | 21 |
| 1999 | 22 |
| 2000 | 32 |
| 2001 | 24 |
| 2002 | 35 |
|
